Stories Library
We proudly offer support and resources to researchers, healthcare providers, patients and their advocates as well as our local communities.
April 17, 2023
Our Impact on Diseases of the Retina: Always Striving for InnovationRegeneron’s unique impact on ophthalmology
Clinical Research & Medicines
August 01, 2021
Moving at Pandemic SpeedRapid response to infectious diseases.
Clinical Research & Medicines
December 02, 2020
Two Targets May Be Better Than OneRegeneron leaders Andres Sirulnik and Israel Lowy discuss why they believe bispecific antibodies may be the next class of medicines to revolutionize cancer treatment.
Clinical Research & Medicines, Research & Preclinical Development
November 21, 2020
The Regeneron Journey: 2020 EditionFollowing an Emergency Use Authorization for casirivimab and imdevimab, Len Schleifer, MD, PhD, Founder and CEO, reflects on what the Regeneron team has accomplished so far in 2020.
Clinical Research & Medicines
October 01, 2020
Listening & Learning From the Rare Disease CommunityDoing right for those living with unmet needs
Clinical Research & Medicines
October 11, 2019
Seeing A New Way For Diabetic RetinopathyRegeneron scientists discuss their motivations for studying diabetic retinopathy, as they work to establish new treatment approaches but also shift mindset around the disease.
Clinical Research & Medicines
October 31, 2018
Making A Drug You Hope No One Will Ever NeedTwenty-five years of discovery and development of medicines at Regeneron have helped millions of people. Leveraging the power of collaboration, we are now working on a medicine to treat Ebola. This is the story of REGN-EB3; a drug we hope no one will ever need.
Clinical Research & Medicines